<h1>Preotact</h1><p> The indication for Preotact is for the treatment of osteoporosis in postmenopausal women at high risk of fractures (see section 5.1of the SmPC).
A significant reduction in the incidence of vertebral fractures but not hip fractures has been demonstrated.</p>
A significant reduction in the incidence of vertebral fractures but not hip fractures has been demonstrated.</p>